Blincyto's label has gradually been extended since 2014, and in December the MHRA approved it as the first immunotherapy for ...

BMS' Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.

Two months ago, state budgeteers were crying the blues over a projected $3 billion-plus budget deficit for the 2025-26 fiscal ...

A research group in Japan identified a correlation between damp heat test of 1,000 hours to 3–6 years of field exposure in ...

During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...

Nearly 5,000 families affected by childhood cancer have received help thanks to Penn State THON, which raises money for Four ...

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

Immunotherapy is the form of treatment that redirects the immune system toward a pathogen or disease. In many cases, ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Hundreds of people in England with aggressive blood cancer are set to benefit from an innovative new treatment that ...

Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood -- known as the tertiary lymphoid structure -- where they become ...